Skip to main content

. 1992 Jan 4;304(6818):35–40. doi: 10.1136/bmj.304.6818.35

Appropriate chemotherapy for palliating advanced cancer.

R D Rubens ¹, K E Towlson ¹, A J Ramirez ¹, S Coltart ¹, M L Slevin ¹, C Terrell ¹, A R Timothy ¹

PMCID: PMC1880912 PMID: 1370911

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Blackledge G., Lawton F., Redman C., Kelly K. Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials. Br J Cancer. 1989 Apr;59(4):650–653. doi: 10.1038/bjc.1989.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rubens R. D. Auditing palliative cancer chemotherapy. Eur J Cancer. 1990;26(10):1023–1025. doi: 10.1016/0277-5379(90)90041-q. [DOI] [PubMed] [Google Scholar]
Slevin M. L., Terry Y., Hallett N., Jefferies S., Launder S., Plant R., Wax H., McElwain T. BACUP--the first two years: evaluation of a national cancer information service. BMJ. 1988 Sep 10;297(6649):669–672. doi: 10.1136/bmj.297.6649.669. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES